Professional Documents
Culture Documents
B2 Review
Saturday, December 13, 2014 at 2:36 PM
B cells
Membrane Ig (BCR) -> Ag
NO
YES
proteins, polysaccharides, lipids,
nucleic acids
linear or conformational
T cells
TCR -> Ag/MHC
YES
NO
proteins mostly, some glycolipids
short linear peptides ONLY
Ig Genetics
B cells
1) CD34+ Common Lymphoid Progenitor
2) IL-7R on CLP with IL-7 on Bone Marrow Stromal cell
3) c-Kit on CLP with SCF (Stem Cell Factor) on Bone Marrow Stromal cells -> commits to B cell lineage
4) Heavy Chain rearrangement
VDJ Somatic Rearrangement
RAG1/2 and RSS Sequences (12/23 Rule = flanking 12 must combine with 23)
5) functional rearrangement induces Allelic Exclusion
other H chain allele gets turned off (assuming the first one was successful)
get 2 tries to make a good H chain
H allele 1
H allele 2
6) Pre-B cell with Pre-BCR
good Heavy Chain gets put with Surrogate Light Chain
7) activating signal via ITAM (Ig-beta and Ig-alpha)
8) Proliferation (Clonal Expansion)
it is hard to make a functional heavy chain
thus after Pre-BCR -> B cell undergoes clonal expansion
each of those daughter cells then undergoes its own L chain rearrangement
increases the odds that one of them will be able to make a functional light chain
9) Light Chain Rearrangement
VJ Somatic Rearrangement
RAG1/2, RSS Sequences (12/23 Rule)
10) functional rearrangement induces Allelic Exclusion
other L chain alleles get turned off
if first try was successful, will turn off the other kappa allele, and the two lambda alleles
have a total of 4 trys to make a good light chain
kappa allele 1
kappa allele 2
lambda allele 1
lambda allele 2
11) Immature B cell
expresses only IgM
12) Tolerance = test Immature B cells for auto-reactivity
if B cell binds to self-antigen:
1) Receptor Editing
RAG1/2 is re-expressed, and Light Chain gene undergoes Somatic Rearrangement again
if new BCR is no longer auto-reactive, cell is allowed to leave BM
2) Apoptosis
if after Receptor Editing, B cell is still auto-reactive -> Apoptosis
3) Anergy = INactivation/paralysis
if BCR binds to SOLUBLE self-antigen
13) B cells leaves Bone Marrow
14) Alternative RNA Splicing of Tandem Constant region genes
will get IgD co-expressed with IgM
RNA Splicing is what combines Constant Region with Variable Region
Constant Region is already encoded for in genome, thus does NOT undergo DNA rearrangement
Primary RNA transcript includes the rearranged Variable Domain, Introns, and the Constant Domain
Splicing creates an mRNA with these sequences adjacent
Somatic Rearrangement
DNA event
1) Recombinatory Signal Sequences (RSS) are brought together by RAG1/2
DJ is first
12 RSS flanking D is brought to 23 RSS flanking J
RAG1/2 cleaves RSSs off, then generates DNA hairpins at the coding ends
2) Artemis opens DNA hairpins -> generates Palindromic P-Nucleotides
3) N-nucleotides are then added on by TdT
Terminal Deoxynucleotidyl Transferase
4) strands are paired
unpaired nucleotides are removed by exonuclease
5) gaps are filled in by Ligase
just the joining of D to J and V to DJ alone is called Combinatorial Diversity
there are many different Vs, Ds and Js to choose from
the addition of P- and N-nucleotides = Junctional Diversity
CDR3 encompasses the joining regions between V, D, and J
therefore CDR3 is the most Hypervariable of the Hypervariable Regions, b/c it includes the Junctional Diversity
CDR1 and CDR2 are fully encoded within the V gene segment
P- and N-nucleotide additions add lots of diversity
however, high chances of adding a frameshift, premature stop codon, etc
this is why most B cells never make it to the Pre-BCR stage, let alone Immature B cell stage
also why it gets so many tries to make a functional heavy and light chain
X-linked Agammaglobulinemia
Brutons Tyrosine Kinase (btk) deficiency
NO activating signal from Pre-BCR
ALL B cells arrest at Pre-B cell stage
therefore NO circulating CD19+ cells (B cells)
B cell Activation
1) BCR on Mature B cell binds to Ag
2) cross-linking of BCRs
Capping = merging of BCRs onto lipid rafts, and those rafts coalescing together
3) Activation Pathway
1) activation of Src Kinases (Lyn)
CD45 Phosphatase removes inhibitory phosphate from Src Kinases
2) phosphorylation of ITAMs
3) recruit and activate Syk
4) activate PLC-gamma
5) PIP2 -> DAG + IP3
6) activation of MAPK, and increase in intracellular Ca2+
7) activation of PKC and Calcineurin
8) activation of TFs
PKC -> NF-kB
MAPK -> AP-1
Calcineurin -> NFAT
4) Clonal Expansion
B cell Positive Co-receptor = CD21, CD19, CD81
decreases threshold for immunogen activation of B cell
1) CD21 binds to C3b on pathogen surface
2) CD19 becomes phosphorylated
3) phosphorylated CD19 binds Src family Kinases and PI3K
4) initiation of downstream signaling
B cell Negative Co-receptor = Fc-gamma-R
overrides Positive Co-receptors
1) Fc-gamma-R binds to Ab that is already bound to Ag
2) ITIM (Inhibition Motif) becomes activated
3) Inhibitory signal starts negative signal cascade
dont need a cop to arrest someone already in handcuffs
Thymus-INdependent Antigens
NO protein domains, but has repeated epitopes
Polysaccharides, Nucleic Acids, etc
T cells can NOT recognize these Ags, thus no T cell help
Steps a B cell undergoes with NO T cell help
1) BCR binds Ag
2) Clonal Expansion
3) production of IgM
NO isotype switching though, so ONLY IgM
4) production of co-stimulatory molecules (CD80/86)
to activate T cells
5) production of Cytokine Receptors
to receive cytokine help from Th cells
only activated B cells therefore are able to receive help from Th cells
resting B cells do not express these receptors, so they just sit idle
6) Migration
B cells move toward T cell zone (PALS or Paracortex)
Characteristics of Thymus INdependent Antigens
TI-1 Antigens
Lipopolysaccharide is major example
Mitogen = binds to a cell and causes clonal expansion (activate ALL cells, regardless of specificity)
LPS binds to TLR4 on ALL B cells -> activates ALL B
Nonspecific, Polyclonal response
TI-2 Antigen
mutlivalent or repetitive epitopes
repeated epitopes cause cross-linking of BCRs -> activation
C3b on pathogen surface binds to Positive Co-receptor and helps
B cell Types
B-2 cells
the conventional B cells
made in BM and main location is secondary lymphoid tissues (lymph nodes, spleen)
B-1 cells
have CD5 marker (which B-2 cells do NOT)
self-renewing, and main location is in body cavities (peritoneal, pleural)
able to make Ab with NO T cell help (since Th cells cant get to them)
B cells activated by Thymus Dependent Antigen
Signal 1 = BCR binds to Ag
Positive Co-receptors also bind to C3b opsonin
B cell becomes APC
expresses co-stimulatory molecules (CD80/CD86), which bind to CD28 on T cell
Signal 2 = CD40L on T cell binds to CD40 on B cell
1) Germinal Centers
clonal expansion -> accumulation of activated B and T cells together in one place
2) Somatic Hypermutation
Activation-Induced cytidine Deaminase (AID) deaminates DNA at Cytosine residues
repair of deaminations results in permanent base changes
3) Affinity Maturation
clonal selection of those BCRs with highest affinity for Ag, after SHM changes
Signal 3 = CD40L on T cell binds CD40 on B cell (again)
1) Isotype Switch
binding of cytokine determines class
IL-4 binding -> IgE
IL-2 binding -> IgG
2) differentiation to Memory or Plasma cell
X-linked Hyper IgM Syndrome
CD40L deficiency
NO Germinal Centers
normal numbers of T and B cells
MHC Molecules
MHC class I
HLA-A, -B, -C
ONE polypeptide alpha chain + beta-2 Microglobulin (non-MHC protein)
expressed on ALL nucleated cells
CD8 binds to alpha-3 domain of MHC-I
alpha-3 domain is conserved, therefore NOT polymorphic
MHC class II
HLA-DP, -DQ, -DR
TWO polypeptide chains = alpha and beta chains
expressed on professional APCs
prevalent in the Thymus, as CD4+ T cell recognize Ag/MHC-II
Homozygous = will express 3 MHC-I
one type of HLA-A, one HLA-B and one HLA-C
3 MHC-II molecules on the surface of their cells
Heterozygous = will express 4-6 MHC-I
up to 2 different HLA-A, 2 HLA-B, 2 HLA-C
4-6 different MHC-II molecules on the surface of their cells
Hybrid MHC-II
since 2 chains combine to form MHC-II, there can be additional polymorphism
Cis = maternal alpha chain + maternal beta chain
Trans = maternal alpha chain + paternal beta chain
Peptide Binding Groove
MHC-I
CLOSED ends
8-10 AAs, strict limit
participating in binding = alpha 1 and alpha 2
Anchor Residues = ends of the groove/peptide
position of the ends of the peptide fragment = buried in the floor of the cleft
MHC-II
OPEN ends
13+ AAs
participating in binding = alpha 1 and beta 1
Anchor Residues = entire length of peptide fragment
position of the ends of the peptide fragment = protruding from the ends of the cleft
Anchor Amino Acid Residues
those AAs on the peptide that specifically bind to the MHC molecule in the groove
Anchor Residues are NOT involved in binding to the TCR
the residues of the peptide fragment that bind to the TCR, are the ones protruding up from the cleft
Antigen Processing and Presentation
MHC class I
ENDOGENOUS pathway
processes proteins made inside the cell
1) defective, aberrant, and/or viral proteins get degraded into peptides by Immunoproteasome
IFN-gamma induces expression of the Immunoproteasome
3 new subunits replace subunits on the Proteasome
IFN-gamma is produced by Th1 cells
Immunoproteasome specifically degrades proteins into peptides suited to bind to MHC-I
2) TAP brings these peptides into the rER
3) ERAP removes N-term AAs to give a peptide that is 8-10 residues
4) MHC-I alpha chain binds Calnexin,Calreticulin until beta-2 Microglobulin binds
5) alpha:microglobulin complex binds to TAP, via Tapasin
6) MHC-I molecule binds peptide of appropriate length and sequence, which was delivered by TAP earlier
7) this completes its folding, and MHC-I is released from TAP and exported to the cell membrane
MHC class II
EXOGENOUS pathway
processes proteins from outside the cell (Ags obtained by endocytosis)
1) endocytosis of extracellular protein
2) that endocytic vesicle fuses with an endosome
3) MHC-II is synthesized in the rER
4) Invariant Chain binds MHC-II, and blocks the binding cleft
Invariant chain also provides the trafficking signal to direct the MHC-II to the lysosome
5) MHC-II with Invariant chain is sent to an acidic lysosome
6) Invariant chain is immediately degraded to CLIP, which remains bound in cleft
7) lysosome fuses with the endosome holding the endocytosed antigenic protein
8) foreign protein is degraded by lysosome acidic proteases
9) HLA-DM removes CLIP from MHC-II
10) HLA-DM grabs different peptides and puts them in the now free binding cleft, until one fits
11) Lysosome fuses with plasma membrane, putting Ag/MHC-II on the surface
EXCEPTION = Dendritic cells
ONLY Dendritic cells are capable of Cross-Presentation
DCs can put Exogenous protein onto MHC-I
CD8+ T cells bind to exogenous Ag/MHC-I -> CTL kills that cell
also, DCs can put Endogenous protein onto MHC-II
another way of getting self-peptides onto MHC molecules
Viruses can block endogenous pathway
1) inhibit TAP, thereby inhibiting peptide transport into ER
2) inhibit peptide binding onto MHC
3) cause MHC-I degradation
Intracellular bacteria block exogenous pathway (Listeria)
1) escape endosomes
2) neutralize endosome acidification
3) block fusion with lysosome
4) sequesters MHC-II after vesicle fusion
CD1 = MHC-I like protein
presents LIPID antigens to NKT cells
NKT cells are T cells with a TCR, but they are specific ONLY to CD1
B3 Review
Saturday, December 13, 2014 at 8:44 PM
List of Molecules
Monday, December 15, 2014 at 9:48 AM
List of CD Molecules
CD1 = MHC-I like molecule that holds lipid antigen and presents it to NKT cells (CD1-restricted T cell)
CD2 = on Lymphocyte, binds to CD58 (LFA-3) on APC
also, Phytohemagglutinin (PHA) binds to CD2 -> polyclonal, systemic activation of T cells
CD3 = Signal Transduction Complex of the TCR
CD4 = Helper T cells, binds to beta-2 invariant region of MHC-II
CD5 = B1 cell marker
CD8 = Cytotoxic T cells, binds to alpha-3 invariant region of MHC-I
CD14 = binds Lipopolysaccharide (Endotoxin), just like TLR-4
CD15 = (Sialyl LewisX), binds to E-Selectins on Endothelium -> Rolling
CD18 = (LFA-1), binds to ICAM-1 on Endothelium -> tight adhesion -> diapedesis
CD19 = pan B2 cell (typical B cell) marker, part of the Positive Co-receptor
gets phosphorylated after CD21 binds C3b on the pathogen surface
CD20 = pan B cell marker
anti-CD20 (Rituxan) is used to treat B cell Lymphoma
CD21 = B cell Positive Co-receptor component that specifically binds to C3b on the surface of the pathogen
CD25 = the alpha chain of the high affinity IL-2 Receptor (IL-2R)
CD28 = on T cell, binds to co-stimulatory molecules CD80/86 (B7) on APC -> 2nd T cell activation Signal
CTLA-4 = on T cell, outcompetes with CD28 for binding to CD80/86, and is inhibitory -> inactivation of T cell
CD34 = Hematopoietic Stem Cell (HSC) marker
CD40 = on B cell, binds to CD40L on Helper T cell -> 2nd and 3rd B cell activating signal
CD40L = on Helper T cell, binds to CD40 on B cell -> 2nd and 3rd B cell activating signal
also binds to CD40 on Macrophage -> increased killing
CD44 = Common Lymphoid Progenitor (CLP) marker
CD45 = Phosphatase activity -> removes inhibitory phosphate from Src Family Kinases (eg Lck)
CD55 = DAF, inhibits MAC lysis of self-cells
CD56 = pan NK cell marker
CD58 = (LFA-3) on APC, binds to CD2 on T cell
CD59 = inhibits MAC lysis of self-cells (along with DAF/CD55)
CD81 = part of the B cell Positive Co-receptor, the Transmembrane spanning domain
CD95 = Fas on cell to be killed, binds to CD95L on CTL or NK cell -> Procaspase 8
CD95L = FasL on CTL or NK cell, binds to CD95 on cell to be killed -> Procaspase 8